Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics
Ahmed M Fatouh,1 Ahmed H Elshafeey,1,2 Ahmed Abdelbary1 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2School of Pharmacy, University of Waterloo, Waterloo, ON, Canada Purpose: Agomelatine is a novel antidepressant drug suffering from an...
Main Authors: | Fatouh AM, Elshafeey AH, Abdelbary A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/intranasal-agomelatine-solid-lipid-nanoparticles-to-enhance-brain-deli-peer-reviewed-article-DDDT |
Similar Items
-
Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation
by: Ahmed M. Fatouh, et al.
Published: (2017-01-01) -
New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan
by: Roxana Popescu, et al.
Published: (2020-07-01) -
Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters
by: Sara Cunha, et al.
Published: (2020-06-01) -
Intranasal button battery: a case series
by: Wan Nur Anis Wan Draman, et al.
Published: (2019-05-01) -
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
by: Cláudia Pina Costa, et al.
Published: (2021-04-01)